Mr. David Soklow is a San Diego, California based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. His current practice location is 6693 Convoy Ct, San Diego. Patients can book an appointment with him at 858-505-0228.
Mr. David Soklow is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. He helps his clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Mr. David Soklow speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Mr. David Soklow
Specialization:
Addiction (Substance Use Disorder) Counselor
Gender:
Male
Accepts Medicare Assignment:
No
Practice Address:
6693 Convoy Ct, San Diego, California, 92111-1008
Phone:
858-505-0228
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1326262122
NPI Enumeration Date:
12 Apr, 2007
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
9324 Lake Hill Rd, Santee, California
Zip:
92071-2133
Patients can reach Mr. David Soklow at 6693 Convoy Ct, San Diego, California or can call to book an appointment on 858-505-0228. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.